Cited by 1,033Cancer Immunotherapy and BiomarkersT-cell and B-cell ImmunologyImmunotherapy and Immune Responses

The DOI matches its Crossref record; 44 of the 45 references it cites were found in a registry or an index.

Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment

Open access

Ma, Xingzhe, Bi, Enguang, Lu, Yong, Su, Pan, Huang, Chunjian, Liu, Lintao, Wang, Qiang, Yang, Maojie, Kalady, Matthew F., Qian, Jianfei, Zhang, Aijun, Gupte, Anisha A., Hamilton, Dale J., Zheng, Chengyun, Yi, Qing·2019·Cell Metabolism

DOI 10.1016/j.cmet.2019.04.002PMC PMC7061417

Open this paper in CoChat — free account Open PDF

Abstract

Tumor-infiltrating T cells often lose their effector function; however, the mechanisms are incompletely understood. We report that cholesterol in the tumor microenvironment induces CD8+ T cell expression of immune checkpoints and exhaustion. Tumor tissues enriched with cholesterol and cholesterol content in tumor-infiltrating CD8+ T cells were positively and progressively associated with upregulated T cell expression of PD-1, 2B4, TIM-3, and LAG-3. Adoptively transferred CD8+ T cells acquired cholesterol, expressed high levels of immune checkpoints, and became exhausted upon entering a tumor. Tumor culture supernatant or cholesterol induced immune checkpoint expression by increasing endoplasmic reticulum (ER) stress in CD8+ T cells. Consequently, the ER stress sensor XBP1 was activated and regulated PD-1 and 2B4 transcription. Inhibiting XBP1 or reducing cholesterol in CD8+ T cells effectively restored antitumor activity. This study reveals a mechanism underlying T cell exhaustion and suggests a new strategy for restoring T cell function by reducing cholesterol to enhance T cell-based immunotherapy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.cmet.2019.04.002

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cancer immunotherapy using checkpoint blockade
Ribas, A., & Wolchok, J. D. (2018) · Science · doi:10.1126/science.aar4060 · Cited by 6,791
T cell exhaustion
Wherry, E. J. (2011) · Nature Immunology · doi:10.1038/ni.2035 · Cited by 4,062 · cited 13×
“Tumor-infiltrating CD8+ T cells are associated with progressive loss of effector function due to prolonged antigen exposure and a suppressive tumor microenvironment (Wherry, 2011).”
Influential
CTLA-4 and PD-1 Pathways: Similarities, Differences, and Implications of Their Inhibition
Buchbinder, E. I., & Desai, A. (2016) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000239 · Cited by 2,360 · cited 1×
“, the combination of anti-PD-1 with anti-CTLA-4 (Buchbinder and Desai, 2016; Duraiswamy et al., 2013; Dyck and Mills, 2017), anti-PD-1 with anti-TIM-3 (Sakuishi et al.”
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
Sakuishi, K., Apetoh, L., Sullivan, J. M., Blazar, B. R., Kuchroo, V. K., & Anderson, A. C. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100643 · Cited by 2,072
Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
Woo, S.-R., Turnis, M. E., Goldberg, M. V., Bankoti, J., Selby, M., Nirschl, C. J., Bettini, M. L., Gravano, D. M., Vogel, P., Liu, C. L., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1620 · Cited by 1,647
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
Boussiotis, V. A. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1514296 · Cited by 1,372
Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments
Angelin, A., Gil‐de‐Gómez, L., Dahiya, S., Jiao, J., Guo, L., Levine, M. H., Wang, Z., Quinn, W. J., Kopinski, P. K., Wang, L., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.12.018 · Cited by 1,304
VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors
Voron, T., Colussi, O., Marcheteau, E., Pernot, S., Nizard, M., Pointet, A.-L., Latreche, S., Bergaya, S., Benhamouda, N., Tanchot, C., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20140559 · Cited by 1,179
Statin use and reduced cancer-related mortality
Nielsen, S. F., Nordestgaard, B. G., & Bojesen, S. E. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1201735 · Cited by 1,030
Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism
Yang, W., Bai, Y., Xiong, Y., Zhang, J., Chen, S., Zheng, X., Meng, X., Li, L., Wang, J., Xu, C., et al. (2016) · Nature · doi:10.1038/nature17412 · Cited by 1,010

Flagged first, then by citations

Show all 45 references

1 of the 45 references couldn’t be matched to a known paper.

Sorted by citations

Items 101–200 of 1,000

IL-9/STAT3/fatty acid oxidation–mediated lipid peroxidation contributes to Tc9 cell longevity and enhanced antitumor activity
Xiao, L., Ma, X., Ye, L., Su, P., Xiong, W., Bi, E., Wang, Q., Xian, M., Yang, M., Qian, J., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci153247 · Cited by 111
Self-citation
Statin drugs enhance responses to immune checkpoint blockade in head and neck cancer models
Kansal, V., Burnham, A. J., Kinney, B. L. C., Saba, N. F., Paulos, C. M., Lesinski, G. B., Buchwald, Z. S., & Schmitt, N. C. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-005940 · Cited by 109
Metabolic regulation of ferroptosis in the tumor microenvironment
Mbah, N. E., & Lyssiotis, C. A. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101617 · Cited by 113
Cancer metabolites: promising biomarkers for cancer liquid biopsy
Wang, W., Rong, Z., Wang, G., Hou, Y., Yang, F., & Qiu, M. (2023) · Biomarker Research · doi:10.1186/s40364-023-00507-3 · Cited by 113
Tumor-secreted FGF21 acts as an immune suppressor by rewiring cholesterol metabolism of CD8+T cells
Hu, C., Qiao, W., Li, X. O., Ning, Z., Liu, J., Dalangood, S., Li, H., Yu, X., Zong, Z., Wen, Z., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.01.005 · Cited by 116
Enhanced CAR-T activity against established tumors by polarizing human T cells to secrete interleukin-9
Liu, L., Bi, E., Ma, X., Xiong, W., Qian, J., Ye, L., Pan, S., Wang, Q., Xiao, L., Yang, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19672-2 · Cited by 106
Self-citation
Atherosclerosis With Immune Checkpoint Inhibitor Therapy
Suero‐Abreu, G. A., Zanni, M. V., & Neilan, T. G. (2022) · JACC CardioOncology · doi:10.1016/j.jaccao.2022.11.011 · Cited by 104
Current Progresses and Challenges of Immunotherapy in Triple-Negative Breast Cancer
Mediratta, K., El‐Sahli, S., D’Costa, V. M., & Wang, L. (2020) · Cancers · doi:10.3390/cancers12123529 · Cited by 102
Dysregulation of cholesterol metabolism in cancer progression
Liu, X., Lv, M., Zhang, W., & Zhan, Q. (2023) · Oncogene · doi:10.1038/s41388-023-02836-x · Cited by 105
Characterizing Intercellular Communication of Pan-Cancer Reveals SPP1+ Tumor-Associated Macrophage Expanded in Hypoxia and Promoting Cancer Malignancy Through Single-Cell RNA-Seq Data
Wei, J., Chen, Z., Hu, M., He, Z., Jiang, D., Long, J., & Du, H. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.749210 · Cited by 107
Lipid Metabolism in Oncology: Why It Matters, How to Research, and How to Treat
Matsushita, Y., Nakagawa, H., & Koike, K. (2021) · Cancers · doi:10.3390/cancers13030474 · Cited by 102
Lipid Metabolism and Cancer Immunotherapy: Immunosuppressive Myeloid Cells at the Crossroad
Bleve, A., Durante, B., Sica, A., & Consonni, F. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165845 · Cited by 101
Radiation-induced PD-L1 expression in tumor and its microenvironment facilitates cancer-immune escape: a narrative review
Wang, N.-H., Lei, Z., Yang, H.-N., Tang, Z., Yang, M., Wang, Y., Sui, J.-D., & Wu, Y. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-6049 · Cited by 106
Self-citation
Novel strategies for cancer immunotherapy: counter-immunoediting therapy
Liu, S., Sun, Q., & Ren, X. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01430-8 · Cited by 107
Nanomaterial-enabled metabolic reprogramming strategies for boosting antitumor immunity
Ma, M., Zhang, Y., Pu, K., & Tang, W. (2024) · Chemical Society Reviews · doi:10.1039/d4cs00679h · Cited by 100
Histone lactylation-driven feedback loop modulates cholesterol-linked immunosuppression in pancreatic cancer
Yang, J., Yu, X., Xiao, M., He, X., Tan, Z., Lei, Y., Guo, Y., Wang, W., Xu, J., Shi, S., et al. (2025) · Gut · doi:10.1136/gutjnl-2024-334361 · Cited by 103
Targeting human Acyl-CoA:cholesterol acyltransferase as a dual viral and T cell metabolic checkpoint
Schmidt, N. M., Wing, P. A. C., Diniz, M. O., Pallett, L. J., Swadling, L., Harris, J. M., Burton, A. R., Jeffery-Smith, A., Zakeri, N., Amin, O. E., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22967-7 · Cited by 96
CD8 + T cell exhaustion in anti‐tumour immunity: The new insights for cancer immunotherapy
Huang, Y., Jia, A., Wang, Y., & Liu, G. (2022) · Immunology · doi:10.1111/imm.13588 · Cited by 96
Nutrients: Signal 4 in T cell immunity
Raynor, J. L., & Chi, H. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20221839 · Cited by 99
Targeting the mevalonate pathway suppresses ARID1A-inactivated cancers by promoting pyroptosis
Zhou, W., Liu, H., Yuan, Z., Zundell, J. A., Towers, M., Lin, J., Lombardi, S., Nie, H., Murphy, B., Yang, T., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.03.002 · Cited by 99
Mannose metabolism reshapes T cell differentiation to enhance anti-tumor immunity
Qiu, Y., Su, Y., Xie, E., Cheng, H., Du, J., Xu, Y., Pan, X., Wang, Z., Chen, D. G., Hong, Z., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.11.003 · Cited by 98
Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment
Wan, M., Pan, S., Shan, B., Diao, H., Jin, H., Wang, Z., Wang, W., Han, S., Liu, W., He, J., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02258-1 · Cited by 102
Emerging role of metabolic reprogramming in tumor immune evasion and immunotherapy
Fan, C., Zhang, S., Gong, Z., Li, X., Xiang, B., Deng, H., Zhou, M., Li, Y., Li, Y., Xiong, W., et al. (2020) · Science China Life Sciences · doi:10.1007/s11427-019-1735-4 · Cited by 92
Lipid nanoparticles allow efficient and harmless ex vivo gene editing of human hematopoietic cells
Vavassori, V., Ferrari, S., Beretta, S., Asperti, C., Albano, L., Annoni, A., Gaddoni, C., Varesi, A., Soldi, M., Cuomo, A., et al. (2023) · Blood · doi:10.1182/blood.2022019333 · Cited by 95
Establishment and validation of a cholesterol metabolism-related prognostic signature for hepatocellular carcinoma
Tang, L., Wei, R., Chen, R., Fan, G., Zhou, J., Qi, Z., Wang, K., Wei, Q., Wei, X., & Xu, X. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.07.030 · Cited by 90
Regulators of CD8+ T cell exhaustion
Sun, Q., & Dong, C. (2025) · Nature reviews. Immunology · doi:10.1038/s41577-025-01221-x · Cited by 91
The crosstalk of CD8+ T cells and ferroptosis in cancer
Lin, Z., Zou, S., & Wen, K. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1255443 · Cited by 91
ATF3 and CH25H regulate effector trogocytosis and anti-tumor activities of endogenous and immunotherapeutic cytotoxic T lymphocytes
Lu, Z. F., McBrearty, N., Chen, J., Tomar, V. S., Zhang, H., Rosa, G. D., Tan, A., Weljie, A. M., Beiting, D. P., Miao, Z., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.08.007 · Cited by 89
AMPK promotes antitumor immunity by downregulating PD-1 in regulatory T cells via the HMGCR/p38 signaling pathway
Pokhrel, R. H., Acharya, S., Ahn, J.-H., Gu, Y., Pandit, M., Kim, J., Park, Y., Kang, B., Ko, H., & Chang, J. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01420-9 · Cited by 91
Methionine consumption by cancer cells drives a progressive upregulation of PD-1 expression in CD4 T cells
Pandit, M., Kil, Y., Ahn, J.-H., Pokhrel, R. H., Gu, Y., Mishra, S. K., Han, Y., Ouh, Y., Kang, B., Jeong, M. S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38316-9 · Cited by 90
Lipid scavenging macrophages and inflammation
Vogel, A., Brunner, J. S., Hajto, A., Sharif, O., & Schabbauer, G. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.159066 · Cited by 92
Multi‐Enzyme Co‐Expressed Nanomedicine for Anti‐Metastasis Tumor Therapy by Up‐Regulating Cellular Oxidative Stress and Depleting Cholesterol
Liu, Y., Niu, R., Deng, R., Wang, Y., Song, S., & Zhang, H. (2023) · Advanced Materials · doi:10.1002/adma.202307752 · Cited by 85
Emerging role of tumor-derived extracellular vesicles in T cell suppression and dysfunction in the tumor microenvironment
Ma, F., Vayalil, J., Lee, G., Wang, Y., & Peng, G. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003217 · Cited by 85
Cellular and molecular waypoints along the path of T cell exhaustion
Lan, X., Zebley, C. C., & Youngblood, B. (2023) · Science Immunology · doi:10.1126/sciimmunol.adg3868 · Cited by 87
Metabolic checkpoints in immune cell reprogramming: rewiring immunometabolism for cancer therapy
Lv, Y., Li, Z., Liu, S., Zhou, Z., Jinling, S., Ba, Y., Weng, S., Zuo, A., Xu, H. W., Luo, P., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02407-6 · Cited by 93
Exosomal cargos-mediated metabolic reprogramming in tumor microenvironment
Tan, S., Yang, Y., Yang, W., Han, Y., Huang, L., Yang, R., Hu, Z., Tao, Y., Liu, L., Li, Y., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02634-z · Cited by 85
Self-citation
Lipid metabolism reprogramming of CD8+ T cell and therapeutic implications in cancer
Wang, R., Liu, Z., Fan, Z., & Zhan, H. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216267 · Cited by 80
Cholesterol Depletion‐Enhanced Ferroptosis and Immunotherapy via Engineered Nanozyme
Bai, T., Xue, P., Shao, S., Yan, S., & Zeng, X. (2024) · Advanced Science · doi:10.1002/advs.202405826 · Cited by 79
A Cholesterol Metabolic Regulated Hydrogen‐Bonded Organic Framework (HOF)‐Based Biotuner for Antibody Non‐Dependent Immunotherapy Tailored for Glioblastoma
Yin, N., Wang, Y., Liu, Y., Niu, R., Zhang, S., Cao, Y., Lv, Z., Song, S., Liu, X., & Zhang, H. (2023) · Advanced Materials · doi:10.1002/adma.202303567 · Cited by 78
Macrophages and T cells in metabolic disorder-associated cancers
Taranto, D., Kloosterman, D. J., & Akkari, L. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00743-1 · Cited by 81
Roles of NK Cell Receptors 2B4 (CD244), CS1 (CD319), and LLT1 (CLEC2D) in Cancer
Buller, C. W., Mathew, P. A., & Mathew, S. O. (2020) · Cancers · doi:10.3390/cancers12071755 · Cited by 76
Tumor microenvironment and immune-related therapies of head and neck squamous cell carcinoma
Qin, Y., Zheng, X., Gao, W., Wang, B., & Wu, Y. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2021.01.011 · Cited by 76
Targeting squalene epoxidase restores anti-PD-1 efficacy in metabolic dysfunction-associated steatohepatitis-induced hepatocellular carcinoma
Wen, J., Zhang, X., Wong, C., Zhang, Y.-T., Pan, Y.-S., Zhou, Y., Cheung, A., Liu, Y.-L., Ji, F.-F., Kang, X., et al. (2024) · Gut · doi:10.1136/gutjnl-2023-331117 · Cited by 71
Fatty Acid Synthesis in Prostate Cancer: Vulnerability or Epiphenomenon?
Sena, L. A., & Denmeade, S. R. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-1392 · Cited by 78
Signatures of EMT, immunosuppression, and inflammation in primary and recurrent human cutaneous squamous cell carcinoma at single-cell resolution
Li, X., Zhao, S., Bian, X., Zhang, L., Lu, L., Pei, S., Dong, L., Shi, W., Huang, L., Zhang, X., et al. (2022) · Theranostics · doi:10.7150/thno.77528 · Cited by 74
Trogocytosis of CAR molecule regulates CAR-T cell dysfunction and tumor antigen escape
Zhai, Y., Du, Y., Li, G., Yu, M., Hu, H., Pan, C., Wang, D., Shi, Z., Yan, X., Li, X., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01708-w · Cited by 74
Roles of Farnesyl-Diphosphate Farnesyltransferase 1 in Tumour and Tumour Microenvironments
Hà, N. T. T., & Lee, C. H. (2020) · Cells · doi:10.3390/cells9112352 · Cited by 73
Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells
Xie, Y., Xie, F., Zhang, L., Zhou, X., Huang, J., Wang, F., Jin, J., Zhang, L., Zeng, L., & Zhou, F. (2021) · Advanced Science · doi:10.1002/advs.202101672 · Cited by 72
Targeting cancer metabolic pathways for improving chemotherapy and immunotherapy
Luo, Z., Eichinger, K. M., Zhang, A., & Li, S. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216396 · Cited by 71
Self-citation
Lipid-loaded macrophages as new therapeutic target in cancer
Marelli, G., Morina, N., Portale, F., Pandini, M., Iovino, M., Di Conza, G., Ho, P.-C., & Di Mitri, D. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-004584 · Cited by 69
Emerging mechanisms of the unfolded protein response in therapeutic resistance: from chemotherapy to Immunotherapy
He, J., Zhou, Y. L., & Sun, L. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01438-0 · Cited by 77
The impact of lipids on the cancer–immunity cycle and strategies for modulating lipid metabolism to improve cancer immunotherapy
Zheng, M., Zhang, W., Chen, X., Guo, H., Wu, H., Xu, Y., He, Q., Ding, L., & Yang, B. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.10.027 · Cited by 68
Targeting metabolism to enhance immunotherapy within tumor microenvironment
Liang, X., Chen, X., Yan, Y., Cheng, A.-Y., Lin, J.-Y., Jiang, Y.-X., Chen, H., Jin, J., & Luan, X. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01304-w · Cited by 69
Revitalizing T cells: breakthroughs and challenges in overcoming T cell exhaustion
Wu, Y., Wu, Y., Gao, Z., Yu, W., Zhang, L., & Zhou, F. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02327-3 · Cited by 78
Solute carrier transporters: emerging central players in tumour immunotherapy
Chen, R., & Chen, L. (2021) · Trends in Cell Biology · doi:10.1016/j.tcb.2021.08.002 · Cited by 69
Regulation of PD-L1 through direct binding of cholesterol to CRAC motifs
Wang, Q., Cao, Y., Shen, L., Xiao, T., Cao, R., Wei, S., Tang, M., Du, L., Wu, H., Wu, B., et al. (2022) · Science Advances · doi:10.1126/sciadv.abq4722 · Cited by 66
Self-citation
Reprogramming of lipid metabolism in the tumor microenvironment: a strategy for tumor immunotherapy
Wu, Y., Pu, X., Wang, X., & Xu, M. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02024-0 · Cited by 66
T cell cholesterol efflux suppresses apoptosis and senescence and increases atherosclerosis in middle aged mice
Bazioti, V., La Rose, A. M., Maassen, S., Bianchi, F., de Boer, R., Halmos, B., Dabral, D., Guilbaud, E., Flohr-Svendsen, A., Groenen, A. G., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31135-4 · Cited by 65
New dawn for cancer cell death: Emerging role of lipid metabolism
Zhang, C., Zhu, N., Li, H., Gong, Y.-Z., Gu, J., Shi, Y., Liao, D., Wang, W., Dai, A., & Li, Q. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101529 · Cited by 67
The effects of metabolism on the immune microenvironment in colorectal cancer
Chen, X., Ma, Z., Yi, Z., Wu, E., Shang, Z., Tuo, B., Li, T., & Liu, X. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01865-z · Cited by 66
Cholesterol metabolism in tumor microenvironment: cancer hallmarks and therapeutic opportunities
Jiang, W. G., Jin, W., & Xu, A. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.92274 · Cited by 70
Metabolic gatekeepers: harnessing tumor-derived metabolites to optimize T cell-based immunotherapy efficacy in the tumor microenvironment
Zheng, Y., Xu, R., Chen, X., Lu, Y., Zheng, J., Lin, Y., Lin, P., Zhao, X., & Cui, L. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-07122-6 · Cited by 66
Self-citation
Optimising NK cell metabolism to increase the efficacy of cancer immunotherapy
Choi, C., & Finlay, D. K. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02377-8 · Cited by 66
Immune checkpoint inhibitor treatment and atherosclerotic cardiovascular disease: an emerging clinical problem
Poels, K., Neppelenbroek, S. I. M., Kersten, M. J., Antoni, M. L., Lutgens, E., & Seijkens, T. T. P. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002916 · Cited by 64
A T cell resilience model associated with response to immunotherapy in multiple tumor types
Zhang, Y., Vu, T., Palmer, D. C., Kishton, R. J., Gong, L., Huang, J., Nguyen, T., Chen, Z., Smith, C., Livák, F., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01799-y · Cited by 64
Endoplasmic reticulum stress responses in anticancer immunity
Hwang, S., Chang, S., Rodrı́guez, P. C., & Cubillos‐Ruiz, J. R. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00836-5 · Cited by 63
WSX1 act as a tumor suppressor in hepatocellular carcinoma by downregulating neoplastic PD-L1 expression
Wu, M., Xia, X., Hu, J., Fowlkes, N. W., & Li, S. (2021) · Nature Communications · doi:10.1038/s41467-021-23864-9 · Cited by 61
Unraveling the Anticancer Potential of Statins: Mechanisms and Clinical Significance
Zaky, M. Y., Fan, C., Zhang, H., & Sun, X. (2023) · Cancers · doi:10.3390/cancers15194787 · Cited by 64
Tumor microenvironmental influences on dendritic cell and T cell function: A focus on clinically relevant immunologic and metabolic checkpoints
Hargadon, K. M. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.37 · Cited by 63
Recent Advances in Reprogramming Strategy of Tumor Microenvironment for Rejuvenating Photosensitizers‐Mediated Photodynamic Therapy
Yu, Q., Li, X., Wang, J., Guo, L., Huang, L., & Gao, W. (2023) · Small · doi:10.1002/smll.202305708 · Cited by 60
Associations of remnant cholesterol with cardiovascular and cancer mortality in a nationwide cohort
Tian, Y., Wu, Y., Qi, M., Song, L., Chen, B., Wang, C., Lu, J., Yang, Y., Zhang, X., Cui, J., et al. (2023) · 中国科学通报：英文版 · doi:10.1016/j.scib.2023.12.035 · Cited by 59
Intracavitary Spraying of Nanoregulator‐Encased Hydrogel Modulates Cholesterol Metabolism of Glioma‐Supportive Macrophage for Postoperative Glioblastoma Immunotherapy
Dong, Y., Zhang, J., Wang, Y., Zhang, Y., Rappaport, D., Yang, Z., Han, M., Liu, Y., Fu, Z., Zhao, X., et al. (2023) · Advanced Materials · doi:10.1002/adma.202311109 · Cited by 59
Identification of FABP5 as an immunometabolic marker in human hepatocellular carcinoma
Liu, F., Liu, W., Zhou, S. Y., Yang, C., Tian, M., Jia, G., Wang, H., Zhu, B., Feng, M., Lü, Y., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000501 · Cited by 58
The ZMYND8-regulated mevalonate pathway endows YAP-high intestinal cancer with metabolic vulnerability
Pan‐Hammarström, Q., Zhong, S., Wang, H., Wang, X., Li, N., Li, Y., Zhang, G., Yuan, H., Lian, Y., Chen, Q., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.04.009 · Cited by 58
Metabolic regulation of T cells in the tumor microenvironment by nutrient availability and diet
Zhao, S., Peralta, R. M., Avina-Ochoa, N., Delgoffe, G. M., & Kaech, S. M. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2021.101485 · Cited by 58
Ferroptosis in cancer immunity and immunotherapy: Multifaceted interplay and clinical implications
Zhai, X., Lin, Y., Zhu, L., Wang, Y., Zhang, J., Liu, J., Li, L., & Lu, X. (2023) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2023.08.004 · Cited by 58
Immunotherapy resistance in non-small cell lung cancer: from mechanisms to therapeutic opportunities
Wang, H., Niu, X., Jin, Z., Zhang, S., Fan, R., Xiao, H., & Hu, S. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03519-z · Cited by 72
MIF as a biomarker and therapeutic target for overcoming resistance to proteasome inhibitors in human myeloma
Wang, Q., Zhao, D., Xian, M., Wang, Z., Bi, E., Su, P., Qian, J., Ma, X., Yang, M., Liu, L., et al. (2020) · Blood · doi:10.1182/blood.2020005795 · Cited by 57
Self-citation
The tumor microenvironment shapes the molecular characteristics of exhausted CD8+ T cells
Cheng, H., Ma, K., Zhang, L., & Li, G. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.02.013 · Cited by 60
Cholesterol Induces Pyroptosis and Matrix Degradation via mSREBP1-Driven Endoplasmic Reticulum Stress in Intervertebral Disc Degeneration
Yan, J., Li, S., Zhang, Y., Deng, Z., Wu, J., Huang, Z., Qin, T., Xiao, Y., Zhou, J., Xu, K., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.803132 · Cited by 56
Cholesterol: An important actor on the cancer immune scene
Halimi, H., & Farjadian, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1057546 · Cited by 56
Targeting metabolic-epigenetic-immune axis in cancer: molecular mechanisms and therapeutic implications
Wang, X., Luo, X., Xiao, R., Liu, X., Zhou, F., Jiang, D., Bai, J., Cui, M., You, L., & Yupei, Z. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02334-4 · Cited by 59
A novel cuproptosis-related lncRNA nomogram to improve the prognosis prediction of gastric cancer
Feng, A., He, L., Chen, T., & Xu, M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.957966 · Cited by 55
Impaired T cell IRE1α/XBP1 signaling directs inflammation in experimental heart failure with preserved ejection fraction
Smolgovsky, S. A., Bayer, A. L., Kaur, K., Sanders, E. K., Aronovitz, M. A., Filipp, M. E., Thorp, E. B., Schiattarella, G. G., Hill, J. A., Blanton, R. M., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci171874 · Cited by 56
The Role of Metabolic Dysfunction in T-Cell Exhaustion During Chronic Viral Infection
Zheng, K., Zheng, X., & Yang, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.843242 · Cited by 56
Strategies to reinvigorate exhausted CD8+ T cells in tumor microenvironment
Guan, Q., Han, M., Guo, Q., Yan, F., Wang, M., Ning, Q., & Xi, D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1204363 · Cited by 57
Cancer immunometabolism: advent, challenges, and perspective
Dang, Q., Li, B., Jin, B., Zeng, Y., Lou, X., Wang, T., Wang, Y., Pan, X., Hu, Q., Li, Z., et al. (2024) · Molecular Cancer · doi:10.1186/s12943-024-01981-5 · Cited by 55
The characteristics of the tumor immune microenvironment in colorectal cancer with different MSI status and current therapeutic strategies
Wang, Q., Yu, M., & Zhang, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1440830 · Cited by 56
Self-citation
Metabolism archetype cancer cells induce protumor TREM2+ macrophages via oxLDL-mediated metabolic interplay in hepatocellular carcinoma
Chu, T., Zhu, G., Tang, Z., Qu, W., Yang, R., Pan, H., Wáng, Y., Tian, R., Chen, L., Guan, Z., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62132-y · Cited by 55
Genkwadaphnin inhibits growth and invasion in hepatocellular carcinoma by blocking DHCR24-mediated cholesterol biosynthesis and lipid rafts formation
Wu, J., Guo, L., Qiu, X., Ren, Y., Li, F., Cui, W., & Song, S. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01085-z · Cited by 54
Role of Lipids and Lipid Metabolism in Prostate Cancer Progression and the Tumor’s Immune Environment
Siltari, A., Syvälä, H., Lou, Y., Gao, Y., & Murtola, T. J. (2022) · Cancers · doi:10.3390/cancers14174293 · Cited by 53
Role of CAR T Cell Metabolism for Therapeutic Efficacy
Saborido, J. R., Völkl, S., Aigner, M., Mackensen, A., & Mougiakakos, D. (2022) · Cancers · doi:10.3390/cancers14215442 · Cited by 56
Immunometabolism of CD8+ T cell differentiation in cancer
Shi, H., Chen, S., & Chi, H. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.03.010 · Cited by 58
Fueling the Revolution: Targeting Metabolism to Enhance Immunotherapy
Leone, R. D., & Powell, J. D. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0791 · Cited by 53
Regulation of macrophage functions by FABP-mediated inflammatory and metabolic pathways
Jin, R., Hao, J., Yi, Y., Sauter, E. R., & Li, B. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.158964 · Cited by 54
PPARα at the crossroad of metabolic–immune regulation in cancer
Zeng, W., Yin, X., Jiang, Y., Jin, L., & Liang, W. P. (2021) · FEBS Journal · doi:10.1111/febs.16181 · Cited by 52
SULT2B1-CS-DOCK2 axis regulates effector T-cell exhaustion in HCC microenvironment
Wang, S., Wang, R., Xu, N., Wei, X., Yang, Y., Lian, Z., Cen, B., Shen, C., Li, W., Wang, J., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000025 · Cited by 52
Molecular fingerprints of cardiovascular toxicities of immune checkpoint inhibitors
Gergely, T. G., Drobni, Z. D., Sayour, N. V., Ferdinandy, P., & Varga, Z. V. (2024) · Basic Research in Cardiology · doi:10.1007/s00395-024-01068-8 · Cited by 54
Targeting T cell exhaustion: emerging strategies in non-small cell lung cancer
Liu, X., Xi, X., Xu, S., Chu, H., Hu, P., Li, D., Zhang, B., Liu, H., Jiang, T., & Lu, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1507501 · Cited by 52
Statins in Cancer Prevention and Therapy
Ricco, N., & Kron, S. J. (2023) · Cancers · doi:10.3390/cancers15153948 · Cited by 53

Authors: Ma, X., Bi, E., Lu, Y., Su, P., Huang, C., Liu, L., Wang, Q., Yang, M., Kalady, M. F., Qian, J., Zhang, A., Gupte, A. A., Hamilton, D. J., Zheng, C., & Yi, Q.
Affiliations: Houston Methodist (US)
Wake Forest University Health Sciences (US)
Cleveland Clinic (US)
Houston Methodist Research Institute (US)
Second Hospital of Shandong University (CN)
Corresponding author: Yi, Qing
ORCID: Ma, Xingzhe
Bi, Enguang
Lu, Yong
Liu, Lintao
Wang, Qiang
Kalady, Matthew F.
Qian, Jianfei
Zhang, Aijun
Gupte, Anisha A.
Hamilton, Dale J.
Zheng, Chengyun
Yi, Qing
Venue: Cell Metabolism
Publisher: Elsevier BV
Published: 2019-07
Volume: 30
Issue: 1
Pages: 143-156.e5
ISSN: 1550-4131 (ISSN-L)
DOI: 10.1016/j.cmet.2019.04.002
PMC: PMC7061417
OpenAlex: W2941036215
Cited by: 1,033
References: 45
Citations by year: 2026: 176 · 2025: 204 · 2024: 187 · 2023: 169 · 2022: 136 · 2021: 100 · 2020: 47 · 2019: 12
FWCI: 31.24
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 367 d)
Locations: Cell Metabolism (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health
Topics: Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords: cholesterol, CD8+ T cell exhaustion, tumor microenvironment, immune checkpoint, PD-1, 2B4, TIM-3, LAG-3, endoplasmic reticulum stress, XBP1, adoptive T cell therapy, antitumor immunity, cholesterol metabolism
MeSH terms: Animals, Cholesterol, Flow Cytometry, Humans, Immunotherapy, Melanoma, Experimental, Blotting, Western, CD8-Positive T-Lymphocytes, Immunoprecipitation, Mice, Tumor Microenvironment, Real-Time Polymerase Chain Reaction, Programmed Cell Death 1 Receptor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks